Geographic Access to CT for Lung Cancer Screening: A Census Tract-Level Analysis of Cigarette Smoking in the United States and Driving Distance to a CT Facility.

Published

Journal Article

PURPOSE: Spatial access to health care resources is a requisite for utilization. Our purpose was to determine, at a census tract level, the geographic distribution of US smokers and their driving distance to an ACR-accredited CT facility. METHODS: The number of smokers per US census tract was determined from US Census Bureau data (American Community Survey, 2011-2015) and census tract smoking prevalence estimates. Driving distance, from the centroid of each census tract to the nearest CT facility, was determined using a geographic information system. Distance variations were assessed, and relationships with tract population density were examined with regression models. RESULTS: Most US smokers (81.8%) were within 15 miles of a CT facility; however, there was considerable inter- and intrastate variability. For census tracts containing ≥500 smokers, median distance to a CT was 4.3 miles. At the state level, median distance ranged from 1.4 (Washington DC) to 29.1 miles (Wyoming). Within each state, this variation was higher, with Washington, DC, exhibiting the lowest range (range, 4.3; 0.2-4.5 miles) and Maine exhibiting the highest range (range, 244.8; 0.2-245.0 miles). Distance to a CT facility was inversely associated with census tract population density. CONCLUSIONS: Geographic variability in CT facility access has implications for lung cancer screening (LCS) implementation. Individuals in densely populated areas have relatively greater spatial access to CT facilities than those in sparsely populated tracts. Further work is needed to identify access disparities to LCS to optimize LCS for all eligible populations.

Full Text

Duke Authors

Cited Authors

  • Tailor, TD; Choudhury, KR; Tong, BC; Christensen, JD; Sosa, JA; Rubin, GD

Published Date

  • January 2019

Published In

Volume / Issue

  • 16 / 1

Start / End Page

  • 15 - 23

PubMed ID

  • 30181089

Pubmed Central ID

  • 30181089

Electronic International Standard Serial Number (EISSN)

  • 1558-349X

Digital Object Identifier (DOI)

  • 10.1016/j.jacr.2018.07.007

Language

  • eng

Conference Location

  • United States